In patients with aortoliliac arterial disease, covered stents conferred a patency advantage compared with bare-metal stents out to 5 years, according to data from the COBEST trial. For the ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Back to Healio In patients with venous outflow ...
Patients with superficial femoral artery (SFA) disease are far more likely to retain primary patency at 1 year when treated with a drug-eluting balloon (DEB) rather than conventional balloon ...
WASHINGTON, DC—In PAD patients, treatment with a second-generation paclitaxel drug-coated balloon (DCB) led to better target vessel patency and less repeat revascularization in a head-to-head ...
ANAHEIM, CA — A new trial shows the combination of aspirin plus ticagrelor (Brilinta, AstraZeneca) resulted in significant improvement in saphenous vein graft (SVG) patency at 12 months compared with ...
A small Chinese trial compared the effects of three oral antispastic medications for 24 weeks post-coronary artery bypass grafting (CABG) in relation to spasm-induced radial artery graft failure.
Superior 1-year patency rates previously observed in the periphery with the Stellarex (Spectranetics) drug-coated balloon (DCB), compared with an uncoated balloon, extend to at least 2 years, suggests ...
MILAN, Aug. 6, 2025 /PRNewswire/ -- Bracco Imaging, a global leader in diagnostic imaging, today announced that its ultrasound contrast agent SonoVue ® has been approved by the China's National ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback